Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PresVu
- Development stage
- Unknown
- Lead developer
- Entod Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
PresVu is a proprietary ophthalmic solution of pilocarpine hydrochloride (1.25%) developed by Entod Pharmaceuticals for the treatment of presbyopia in adults. It utilizes Dynamic Buffer Technology to adapt to the physiological pH of the tear film, enhancing comfort and ensuring consistent efficacy. Pilocarpine acts as a cholinergic muscarinic receptor agonist, stimulating the muscarinic receptors on the iris sphincter muscle to cause pupil constriction (miosis) and on the ciliary muscle to facilitate accommodation, thereby temporarily improving near and intermediate vision. Although its manufacturing and marketing license in India was temporarily suspended by the CDSCO in September 2024 due to unauthorized promotional claims, the suspension was revoked in April 2025, allowing for its commercial launch.
- Brand names
- PresVu
- Other names
- pilocarpine hydrochloride 1.25% ophthalmic solution
02
Targets
CHRM3 (M3)
Beyond the preview
Go deeper on PresVu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PresVu.